Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer

NCT01839500

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Gastric Cancer

Interventions: Trastuzumab

Countries: China

This prospective, multi-center, non-interventional study will evaluate the efficacy and safety of trastuzumab in routine clinical practice in Chinese participants with gastric or gastro-oesophageal cancer. The study will be conducted in 5 cohorts and eligible participants will be enrolled and assigned to the various cohorts according to human epidermal growth factor receptor 2 (HER2) status, disease stage and treatment with trastuzumab according to physician's decision. Treatment patterns and clinical outcomes in participants with gastric cancer in China will be evaluated. The total study duration is 60 months.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

General Inclusion Criteria:

* Histologically confirmed cancer of the stomach or gastro-oesophageal junction or recurrent disease within 6 months before the date of recruitment
* Documented participant with trackable medical records
* HER2 status by immunohistochemistry (IHC) is known

Specific Inclusion Criteria:

* Cohort I/II/IV: Participants with mGC: with recurrent or metastatic disease or with inoperable locally advanced disease
* Cohort III/V: Participants with operable non-mGC: TxNxM0 (according to American Joint Committee on Cancer \[AJCC\] edition 7th)

Exclusion Criteria:

* Participants receiving regimen in a blinded trial
Locations (81)
  • Anyang, China
  • Beijing, China
  • Beijing, China
  • Beijing, China
  • Beijing, China
  • Beijing, China
  • Beijing, China
  • Beijing, China
  • Changchun, China
  • Changsha, China
  • Changsha, China
  • Changzhou, China
  • Chengdu, China
  • Chengdu, China
  • Chengdu, China
  • Chongqing, China
  • Foshan, China
  • Fujian, China
  • Fuzhou, China
  • Fuzhou, China
  • Guangzhou, China
  • Guangzhou, China
  • Guangzhou, China
  • Guiyang, China
  • Guiyang, China
  • Haikou, China
  • Hangzhou, China
  • Hangzhou, China
  • Harbin, China
  • Hefei, China
  • + 51 more on CT.gov